About the Book
Separating myth from fact, this authoritative work reviews the breadth of current knowledge about methamphetamine addiction and describes the most promising available treatment approaches. Leading experts present state-of-the-art information on the effects of methamphetamine on the brain, body, mental health, and behavior. Psychosocial and pharmacological treatment strategies are critically evaluated, including approaches to treating dually diagnosed clients. Written in a concise, accessible style, the volume emphasizes that recovery is possible, despite the significant challenges the drug poses. The authors identify key avenues for collaboration among clinical, public health, and other professionals.
Table of Contents:
1.Introduction, John M. Roll, Richard A. Rawson, Steven Shoptaw, and Walter Ling
2. Epidemiology of Methamphetamine Use: A Global Perspective, Beth A. Rutkowski and Jane C. Maxwell
3. Basic Neuropharmacological Mechanisms of Methamphetamine, Glen R. Hanson and Annette E. Fleckenstein
4. Methamphetamine and the Brain: Findings from Brain Imaging Studies, Doris Payer and Edythe D. London
5. Behavioral Pharmacology and Psychiatric Consequences of Methamphetamine, Craig R. Rush, William W. Stoops, and Walter Ling
6. Medical Effects of Methamphetamine Use, Larissa Mooney, Suzette Glasner-Edwards, Richard A. Rawson, and Walter Ling
7. Public Health Issues Surrounding Methamphetamine Dependence, Steven Shoptaw, William D. King, Evan Landstrom, Michelle A. Bholat, Keith Heinzerling, Gregory D. Victorianne, and John M. Roll
8. Methamphetamine and Crime, David Farabee and Angela Hawken
9. Effects of Methamphetamine on Communities, Linda J. Thompson, Sharon Sowell, and John M. Roll
10. Psychosocial and Behavioral Treatment of Methamphetamine Dependence, Steven Shoptaw, Richard A. Rawson, Matthew Worley, Sarah Lefkowith, and John M. Roll
11. Pharmacological Treatment of Methamphetamine Addiction, Frank J. Vocci, Ahmed Elkashef, and Nathan M. Appel
12. Treatment of Methamphetamine Addiction That Co-occurs with Serious Mental Illness, Jagoda Pasic and Richard Ries
13. Conclusion, Charles R. Schuster, Chris-Ellyn Johanson, and John M. Roll
About the Author :
John M. Roll, PhD, is Professor and Associate Dean for Research at Washington State University College of Nursing in Spokane and Director of its Program of Excellence in the Addictions. He is a Fellow of the American Psychological Association, President of the association's Division on Psychopharmacology and Substance Abuse, and was a vice-chairman of the Washington State Governor’s Council on Substance Abuse. Dr. Roll has received research funding from federal, state, and local sources, as well as foundation and industry support.
Richard A. Rawson, PhD, is Associate Director of the UCLA Integrated Substance Abuse Programs, one of the foremost substance abuse research groups, and Professor-in-Residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Rawson oversees clinical trials on pharmacological and psychosocial addiction treatments. He served on the Federal Methamphetamine Advisory Group from 1996 to 1999.
Walter Ling, MD, is a board-certified neurologist and psychiatrist, Professor- in-Residence of Psychiatry at the David Geffen School of Medicine at the University of California, Los Angeles, and Director of the UCLA Integrated Substance Abuse Programs. He is a consultant for numerous local, national, and international private and public agencies. Dr. Ling's current research program is designed to bring cutting-edge findings from treatment research to practice in community treatment programs.
Steven Shoptaw, PhD, is Professor of Family Medicine and of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Shoptaw’s research involves developing and implementing efficacious treatments for individuals with various drug dependence problems, particularly for those with stimulant dependence and risks for HIV infection and other health care problems.
Review :
"This definitive, timely book broadens the understanding of methamphetamine addiction and its treatment with in-depth coverage of such diverse topics as epidemiology, neuropharmacology, psychiatric consequences, psychosocial interventions, and pharmacological interventions. Grounded in research data and clinical experience, the book will be of immense value to practitioners, researchers, and students." - Arnold M. Washton, Executive Director, Recovery Options, New York, New York, and Princeton, New Jersey, USA "The field has clearly been lacking a comprehensive reference like this one. Contributors include foremost experts, who offer up-to-date, authoritative presentations. This information should be widely disseminated among treatment professionals as we confront this grave addiction that affects so many Americans." - Thomas R. Kosten, Jay H. Waggoner Chair and Professor of Psychiatry and Neuroscience, Baylor College of Medicine, USA "This skillfully crafted volume belongs in the library of every addictions professional. Among the book's unique contributions is the way it addresses methamphetamine at multiple levels of analysis, from cellular effects and community impacts to best practices in treatment and prevention. It also goes a long way in correcting popular misconceptions. Given its coherence and breadth, this book is well suited to be a supplemental text in graduate-level courses on addictions. Students will benefit greatly from the integrated coverage of biological, psychological, social, and environmental factors in methamphetamine addiction and its treatment." - Meredith Hanson, Professor and Director, Doctoral Program in Social Work, Fordham University Graduate School of Social Service, USA
